FDA Inspection 997487 — Kowa Company, Ltd.
The FDA completed an inspection of Kowa Company, Ltd. on December 9, 2016 in Nagoya. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- December 9, 2016
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Nagoya (Japan)